1 completed, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Anticoagulants and Bleeding Disorders: new trials by email Literature Review of Anticoagulants and Bleeding Disorders trials Research Report on Anticoagulants and Bleeding Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO Argatroban, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Anticoagulants and Bleeding Disorders | Phase 2 / Phase 3 | Completed | Medical University of Vienna | 40 | 2021-12-01 | 2024-09-19 |
| Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis Rivaroxaban 15 mg, Warfarin - Prostheses and Implants, Stroke | Phase 2 / Phase 3 | Terminated | Hospital Geral Roberto Santos | 50 | 2018-07-10 | 2020-05-15 |
Hemostatic Disorders (2) · Heart Valve Diseases (1) · Stroke (1)
Cardiovascular Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Vascular Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Heart Diseases (1) · Nervous System Diseases (1)
Heparin (1) · Rivaroxaban (1) · Warfarin (1) · acarboxyprothrombin (1) · argatroban (1)
Hospital Geral Roberto Santos (1) · Medical University of Vienna (1)
Austria (1) · Brazil (1)
Andre Duraes, PhD (1) · Thomas Staudinger, MD (1)